Big pharma companies warn against loosening rules on intellectual property

  • 📰 IrishTimes
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 98%

Business News News

Business Business Latest News,Business Business Headlines

New EU strategy due this month will focus on improving affordability of and access to medicines across member states

Ipha says the new EU strategy comes at a pivotal moment as Europe “struggles to regain the ground it has lost to the US and China for cutting-edge science and investment”.

The industry believes it can offer solutions on access and affordability without loosening IP rights, saying that measures already proposed could deliver results by next year. Ipha president Michael O’Connell said the industry was Europe’s largest high-tech industry, employing 840,000 and investing €42 billion each year in European R&D.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

To the surprise of no-one.😡

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSİNESS

Business Business Latest News, Business Business Headlines